Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Ocular conditions and dry eye due to traditional and new forms of smoking: A review.

Makrynioti D, Zagoriti Z, Koutsojannis C, Morgan PB, Lagoumintzis G.

Cont Lens Anterior Eye. 2020 Feb 25. pii: S1367-0484(20)30027-8. doi: 10.1016/j.clae.2020.02.009. [Epub ahead of print] Review.

PMID:
32111452
2.

Wireless Direct Microampere Current in Wound Healing: Clinical and Immunohistological Data from Two Single Case Reports.

Lagoumintzis G, Zagoriti Z, Jensen MS, Argyrakos T, Koutsojannis C, Poulas K.

Biosensors (Basel). 2019 Sep 5;9(3). pii: E107. doi: 10.3390/bios9030107.

3.

Real-Time Assessment of E-Cigarettes and Conventional Cigarettes Emissions: Aerosol Size Distributions, Mass and Number Concentrations.

Lampos S, Kostenidou E, Farsalinos K, Zagoriti Z, Ntoukas A, Dalamarinis K, Savranakis P, Lagoumintzis G, Poulas K.

Toxics. 2019 Aug 30;7(3). pii: E45. doi: 10.3390/toxics7030045.

4.

Toxicity classification of e-cigarette flavouring compounds based on European Union regulation: analysis of findings from a recent study.

Farsalinos K, Lagoumintzis G.

Harm Reduct J. 2019 Jul 25;16(1):48. doi: 10.1186/s12954-019-0318-2.

5.

Microwave diathermy induces mitogen-activated protein kinases and tumor necrosis factor-α in cultured human monocytes.

Lagoumintzis G, Andrikopoulos A, Adamopoulos A, Seimenis I, Koutsojannis C.

Electromagn Biol Med. 2019;38(3):218-229. doi: 10.1080/15368378.2019.1613426. Epub 2019 May 11.

PMID:
31079506
6.

Tobacco-specific nitrosamines: A literature review.

Konstantinou E, Fotopoulou F, Drosos A, Dimakopoulou N, Zagoriti Z, Niarchos A, Makrynioti D, Kouretas D, Farsalinos K, Lagoumintzis G, Poulas K.

Food Chem Toxicol. 2018 Aug;118:198-203. doi: 10.1016/j.fct.2018.05.008. Epub 2018 May 8. Review.

PMID:
29751076
7.

Evidence for association of STAT4 and IL12RB2 variants with Myasthenia gravis susceptibility: What is the effect on gene expression in thymus?

Zagoriti Z, Lagoumintzis G, Perroni G, Papathanasiou G, Papadakis A, Ambrogi V, Mineo TC, Tzartos JS, Poulas K.

J Neuroimmunol. 2018 Jun 15;319:93-99. doi: 10.1016/j.jneuroim.2018.03.008. Epub 2018 Mar 17.

PMID:
29576322
8.

TA-GC cloning: A new simple and versatile technique for the directional cloning of PCR products for recombinant protein expression.

Niarchos A, Siora A, Konstantinou E, Kalampoki V, Lagoumintzis G, Poulas K.

PLoS One. 2017 Nov 1;12(11):e0186568. doi: 10.1371/journal.pone.0186568. eCollection 2017.

9.

Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice.

Ziros P, Zagoriti Z, Lagoumintzis G, Kyriazopoulou V, Iskrenova RP, Habeos EI, Sykiotis GP, Chartoumpekis DV, Habeos IG.

PLoS One. 2016 Sep 1;11(9):e0162024. doi: 10.1371/journal.pone.0162024. eCollection 2016.

10.

Utilizing the virus-induced blocking of apoptosis in an easy baculovirus titration method.

Niarchos A, Lagoumintzis G, Poulas K.

Sci Rep. 2015 Oct 22;5:15487. doi: 10.1038/srep15487.

11.

Reduced muscle mitochondrial enzyme activity in MuSK-immunized mice.

Özkök E, Durmuş H, Yetimler B, Taşlı H, Trakas N, Ulusoy C, Lagoumintzis G, Tzartos S, Tüzün E.

Clin Neuropathol. 2015 Nov-Dec;34(6):359-63. doi: 10.5414/NP300875.

PMID:
26365462
12.

Introducing dAUTObase: a first step towards the global scale geoepidemiology of autoimmune syndromes and diseases.

Gkantouna VA, Kambouris ME, Viennas ES, Ioannou ZM, Paraskevas M, Lagoumintzis G, Zagoriti Z, Patrinos GP, Tzimas GE, Poulas K.

Bioinformatics. 2015 Feb 15;31(4):581-6. doi: 10.1093/bioinformatics/btu690. Epub 2014 Oct 20.

PMID:
25332376
13.

Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.

Kordas G, Lagoumintzis G, Sideris S, Poulas K, Tzartos SJ.

PLoS One. 2014 Sep 26;9(9):e108327. doi: 10.1371/journal.pone.0108327. eCollection 2014. Erratum in: PLoS One. 2015;10(1):e0117673. PLoS One. 2015 Mar 25;10(3):e0120947.

14.

Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies.

Lagoumintzis G, Zisimopoulou P, Trakas N, Grapsa E, Poulas K, Tzartos SJ.

J Neuroimmunol. 2014 Feb 15;267(1-2):1-6. doi: 10.1016/j.jneuroim.2013.11.001. Epub 2013 Nov 10.

PMID:
24412396
15.

Antigen-specific apheresis of autoantibodies in myasthenia gravis.

Lazaridis K, Zisimopoulou P, Lagoumintzis G, Skriapa L, Trakas N, Evangelakou P, Kanelopoulos I, Grapsa E, Poulas K, Tzartos S.

Ann N Y Acad Sci. 2012 Dec;1275:7-12. doi: 10.1111/j.1749-6632.2012.06788.x.

PMID:
23278571
16.

A critical view of the general public's awareness and physicians' opinion of the trends and potential pitfalls of genetic testing in Greece.

Mai Y, Koromila T, Sagia A, Cooper DN, Vlachopoulos G, Lagoumintzis G, Kollia P, Poulas K, Stathakopoulos V, Patrinos GP.

Per Med. 2011 Sep;8(5):551-561. doi: 10.2217/pme.11.48.

PMID:
29793257
17.

ETHNOS : A versatile electronic tool for the development and curation of national genetic databases.

van Baal S, Zlotogora J, Lagoumintzis G, Gkantouna V, Tzimas I, Poulas K, Tsakalidis A, Romeo G, Patrinos GP.

Hum Genomics. 2010 Jun;4(5):361-8.

18.

Genetic databases and their potential in pharmacogenomics.

Lagoumintzis G, Poulas K, Patrinos GP.

Curr Pharm Des. 2010;16(20):2224-31. Review.

PMID:
20459387
19.

Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis.

Lagoumintzis G, Zisimopoulou P, Kordas G, Lazaridis K, Poulas K, Tzartos SJ.

Autoimmunity. 2010 Aug;43(5-6):436-45. doi: 10.3109/08916930903518099. Review.

PMID:
20187712
20.

Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses.

Mattheolabakis G, Lagoumintzis G, Panagi Z, Papadimitriou E, Partidos CD, Avgoustakis K.

Int J Pharm. 2010 Jan 29;385(1-2):187-93. doi: 10.1016/j.ijpharm.2009.10.033. Epub 2009 Oct 27.

PMID:
19874877
21.

Synergistic regulation of Pseudomonas aeruginosa-induced cytokine production in human monocytes by mannose receptor and TLR2.

Xaplanteri P, Lagoumintzis G, Dimitracopoulos G, Paliogianni F.

Eur J Immunol. 2009 Mar;39(3):730-40. doi: 10.1002/eji.200838872.

22.

Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.

Zisimopoulou P, Lagoumintzis G, Kostelidou K, Bitzopoulou K, Kordas G, Trakas N, Poulas K, Tzartos SJ.

J Neuroimmunol. 2008 Sep 15;201-202:95-103. doi: 10.1016/j.jneuroim.2008.06.020. Epub 2008 Jul 29. Review.

PMID:
18667243
23.

Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains.

Zisimopoulou P, Lagoumintzis G, Poulas K, Tzartos SJ.

J Neuroimmunol. 2008 Aug 30;200(1-2):133-41. doi: 10.1016/j.jneuroim.2008.06.002. Epub 2008 Jul 7.

PMID:
18603305
24.

Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.

Tzartos SJ, Bitzopoulou K, Gavra I, Kordas G, Jacobson L, Kostelidou K, Lagoumintzis G, Lazos O, Poulas K, Sideris S, Sotiriadis A, Trakas N, Zisimopoulou P.

Ann N Y Acad Sci. 2008;1132:291-9. doi: 10.1196/annals.1405.017.

PMID:
18567880
26.

Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.

Kalamida D, Poulas K, Avramopoulou V, Fostieri E, Lagoumintzis G, Lazaridis K, Sideri A, Zouridakis M, Tzartos SJ.

FEBS J. 2007 Aug;274(15):3799-845. Review.

27.

Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture.

Sideris S, Lagoumintzis G, Kordas G, Kostelidou K, Sotiriadis A, Poulas K, Tzartos SJ.

J Neuroimmunol. 2007 Sep;189(1-2):111-7. Epub 2007 Jul 6.

PMID:
17617475

Supplemental Content

Loading ...
Support Center